{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:25:11Z","timestamp":1790645111626,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.radonc.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T22:26:36Z","timestamp":1422570396000},"page":"182-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Re-irradiation of adenoid cystic carcinoma: Analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy"],"prefix":"10.1016","volume":"114","author":[{"given":"Alexandra D.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Poulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Nikoghosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naved","family":"Chaudhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc W.","family":"M\u00fcnter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus K.","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.01.002_b0005","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO;2-Y","article-title":"Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin","volume":"60","author":"Dreyfuss","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.01.002_b0010","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdr522","article-title":"A phase II study of sunitinib in recurrent and\/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC","volume":"23","author":"Chau","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/hed.23647","article-title":"A phase II study of gefitinib in patients with advanced salivary gland cancers","author":"Jakob","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.01.002_b0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.2005.06.125","article-title":"Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital Phase II Consortium Study","volume":"23","author":"Hotte","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.oraloncology.2008.07.010","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0030","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.6020","article-title":"Sorafenib in recurrent and\/or metastatic salivary gland carcinomas (RMSGCs): an investigator-initiated phase II trial (NCT01703455)","volume":"31","author":"Locati","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0360-3016(88)90297-0","article-title":"Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy","volume":"15","author":"Weichselbaum","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0360-3016(86)90093-3","article-title":"Re-irradiation of advanced tumors of the head and neck with fast neutrons","volume":"12","author":"Errington","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0360-3016(88)90354-9","article-title":"Re-irradiation of locally recurrent tumors with fast neutrons","volume":"15","author":"Saroja","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0050","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","article-title":"Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma","volume":"26","author":"Janot","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2005.07.005","article-title":"Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma","volume":"64","author":"Salama","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0060","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.2008.20.0691","article-title":"Prognostic factors for survival after salvage reirradiation of head and neck cancer","volume":"27","author":"Tanvetyanon","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ijrobp.2006.12.055","article-title":"Salvage re-irradiation for recurrent head and neck cancer","volume":"68","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/oxfordjournals.annonc.a010793","article-title":"Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease","volume":"7","author":"Haraf","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.radonc.2009.10.012","article-title":"Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory","author":"Duprez","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0080","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ijrobp.2008.10.013","article-title":"Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer","volume":"74","author":"Roh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/COC.0b013e3181aacba5","article-title":"Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience","volume":"33","author":"Rwigmena","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0168-9002(93)91335-K","article-title":"Magnetic scanning system for heavy ion therapy","volume":"330","author":"Haberer","year":"1993","journal-title":"Nucl Instrum Methods Phys Res"},{"key":"10.1016\/j.radonc.2015.01.002_b0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1748-717X-7-51","article-title":"Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT","volume":"7","author":"Jensen","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0360-3016(01)01599-1","article-title":"Extent and kinetics of recovery of occult spinal cord injury","volume":"50","author":"Ang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2015.01.002_b0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.radonc.2015.01.002_b0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2011.05.017","article-title":"Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: acute toxicity and feasibility","volume":"101","author":"Jensen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0120","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","article-title":"Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group protocol 9911","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0125","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1200\/JCO.1998.16.11.3556","article-title":"Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients","volume":"16","author":"De Crevoisier","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.20697","article-title":"Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck","author":"Spencer","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.01.002_b0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0360-3016(01)01456-0","article-title":"Conformal re-irradiation of recurrent and new primary head-and-neck cancer","volume":"50","author":"Dawson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/ajot.2002.124540","article-title":"Complications following re-irradiation for head and neck cancer","volume":"23","author":"Ohizumi","year":"2002","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.radonc.2015.01.002_b0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2006.02.003","article-title":"A phase II study of primary reirradiation in squamous cell carcinoma of head and neck","author":"Langendijk","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hed.20986","article-title":"Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiatied head and neck cancers","author":"Watkins","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.01.002_b0155","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijrobp.2011.01.004","article-title":"Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity","volume":"81","author":"Hoebers","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0160","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ijrobp.2008.10.042","article-title":"The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets","volume":"74","author":"Popovtzer","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2013.08.012","article-title":"Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer","volume":"109","author":"Lartigau","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0170","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ijrobp.2008.12.075","article-title":"Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial","volume":"75","author":"Heron","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/hed.20786","article-title":"Outcomes following reirradiation of patients with head and neck cancer","volume":"30","author":"Goldstein","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.01.002_b0180","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1002\/cncr.25305","article-title":"Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer","volume":"116","author":"Sher","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.01.002_b0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.04.021","article-title":"IMRT reirradiation of head and neck cancer \u2013 disease control and morbidity outcomes","volume":"73","author":"Sulman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.radonc.2010.03.006","article-title":"Chemoreirradiation for recurrent salivary gland malignancies","volume":"95","author":"Pederson","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0195","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hed.21889","article-title":"Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck","volume":"34","author":"Vargo","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.01.002_b0200","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0360-3016(92)90663-3","article-title":"Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation","volume":"23","author":"Feehan","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ijrobp.2010.03.001","article-title":"Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect model","volume":"80","author":"Schlampp","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2010.08.029","article-title":"Risk of carotid blowout after reirradiation of the head and neck: a systematic review","volume":"82","author":"McDonald","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.01.002_b0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cncr.21158","article-title":"Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques","volume":"104","author":"Schulz-Ertner","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.01.002_b0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2011.12.013","article-title":"Results of carbon ion radiotherapy for head and neck cancer","volume":"103","author":"Mizoe","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hed.20327","article-title":"Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group","volume":"28","author":"Gilbert","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.01.002_b0230","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y","article-title":"Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies","volume":"91","author":"Airoldi","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.01.002_b0235","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.24745","article-title":"A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group","volume":"116","author":"Laurie","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.01.002_b0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2010.10.010","article-title":"Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region","volume":"98","author":"Combs","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0245","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.01.002_b0250","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1002\/cncr.25852","article-title":"A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: trial of the Eastern Cooperative Oncology Group (E1303)","volume":"117","author":"Argiris","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.01.002_b0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.24745","article-title":"A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC clinical trials group","volume":"116","author":"Laurie","year":"2010","journal-title":"Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T23:54:29Z","timestamp":1651103669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0167814015000274"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.01.002","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-irradiation of adenoid cystic carcinoma: Analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}